Építés alatt – nem éles oldal
Belépés

What researchers published on Mezotelióma

6203 papers, newest first.

Showing 40 of 6203

  • RETRACTED: Ramundo et al. APE-1/Ref-1 Inhibition Blocks Malignant Pleural Mesothelioma Cell Proliferation and Migration: Crosstalk Between Oxidative Stress and Epithelial Mesenchymal Transition (EMT) in Driving Carcinogenesis and Metastasis. Int. J. Mol. Sci. 2023, 24, 12570.International journal of molecular sciences
  • Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma.Cureus
  • The Sibaté Asbestos-Cement Facility Case Study: Reconstructing the Production Process to Assess Occupational and Environmental Impacts.Annals of global health
  • ÁttekintésReview of Registries, Databases and Biobanks for Surveillance and Research on Mesothelioma.Cancers
  • ÁttekintésBeyond Mesothelioma: From Diagnostic Biomarker to Therapeutic Opportunity-The Emerging Role of MTAP in Cancer.International journal of molecular sciences
  • Real-World Outcomes of Oral VEGFR Tyrosine Kinase Inhibitor-Containing Therapy in Unresectable Malignant Mesothelioma: A Single-Center Retrospective Study.Cancers
  • Correction: Machine learning, molecular docking, and experimental validation identify shared molecular signatures between idiopathic pulmonary arterial hypertension and malignant pleural mesothelioma: a retrospective study.Frontiers in genetics
  • Recent advances in the treatment of pleural mesothelioma.Current opinion in oncology
  • Targeting the CCL5-CCR5 axis protects against chemoresistant mesothelioma development through macrophage reprogramming.Cancer letters
  • High-Pressure/High-Dose Versus Standard PIPAC in Epithelioid Peritoneal Mesothelioma: Safety, Feasibility, and Outcomes From a Bicentric Comparative Cohort Study.Annals of surgical oncology
  • Evolution and distribution of malignant pleural mesothelioma mortality in Spain: 2016-2022.Pulmonology
  • Outcomes of Platinum plus /Pemetrexed Rechallenge in Pleural Mesothelioma: The Role of Platinum-Free Interval in a Multicenter Real-World Analysis.JTO clinical and research reports
  • Multiomics Analysis of Malignant Pleural Mesothelioma Reveals the Immunological Microenvironment Associated with MTAP Loss and Immunotherapy Outcomes.Clinical cancer research : an official journal of the American Association for Cancer Research
  • [Current State of the Asbestos Outpatient Clinic and an Evaluation of Asbestos Bodies].Kyobu geka. The Japanese journal of thoracic surgery
  • Esetismertetés[Surgical Case of Primary Malignant Pericardial Mesothelioma].Kyobu geka. The Japanese journal of thoracic surgery
  • USP14 promotes malignant pleural mesothelioma progression and suppresses autophagy by stabilizing the YAP1-TEAD4 axis.Molecular biology reports
  • ÁttekintésCross-lineage mesenchymal transition in mesothelioma.Cancer metastasis reviews
  • Prognostic factors after multimodality treatment for pleural mesothelioma.Interdisciplinary cardiovascular and thoracic surgery
  • Prognostic associations of PD-L1 expression and BAP1 loss in pleural mesothelioma: a retrospective single-center cohort from Colombia.Frontiers in oncology
  • Multimodality imaging in the diagnosis and staging of malignant pleural mesothelioma.BMJ case reports
  • Anti-Ma1/Ma2 paraneoplastic neurological syndrome associated with malignant mesothelioma: a case study.BMJ neurology open
  • Machine learning, molecular docking, and experimental validation identify shared molecular signatures between idiopathic pulmonary arterial hypertension and malignant pleural mesothelioma: a retrospective study.Frontiers in genetics
  • Post-Recurrence Treatment Patterns and Outcomes After Curative-Intent Multimodality Strategy in Patients with Pleural Mesothelioma: A Retrospective Cohort Study.Journal of clinical medicine
  • Prognostic Significance of B7-H3, TROP2, and p16 Expression in Pleural Mesothelioma: Clinicopathological Correlations and Survival Outcomes.Journal of clinical medicine
  • Treatment-specific Association of H&E-based Stromal Tumor-infiltrating Lymphocytes With Survival in Pleural Mesothelioma Treated With Ipilimumab/Nivolumab or Chemotherapy.Anticancer research
  • ÁttekintésMTAP Loss and Pleural Mesothelioma (PM): Current Treatment Strategies and Emerging Therapeutic Approaches.Cancers
  • Correction: Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype.PloS one
  • Integrative Bioinformatics and Machine Learning Approaches for Biomarker and Pathway Discovery in Malignant Pleural Mesothelioma.Cancer reports (Hoboken, N.J.)
  • HMGB1 directly activates BAP1 transcription to sustain tumor growth in mesothelioma.Cell death and differentiation
  • ÁttekintésReprogramming the tumor microenvironment in mesothelioma: from immune suppression to therapeutic opportunity.Frontiers in immunology
  • EsetismertetésUltrasonic manifestations of diffuse pericardial mesothelioma masquerading as pericardial effusion: a case report.Frontiers in oncology
  • When art anticipates disease: asbestos, conceptual painting and mesothelioma.Medical humanities
  • Randomised pilot and feasibility study comparing video-assisted thoracoscopic partial pleurectomy-decortication with indwelling pleural catheter for trapped lung in pleural mesothelioma.Thorax
  • Beyond the pleura: National trends in mesothelioma mortality by anatomical site in Spain, 1999-2024.Cancer epidemiology
  • Hexokinase II as a Potential Target of Apigenin Through the Induction of Apoptosis and Necroptosis in Malignant Mesothelioma.Nutrients
  • Awareness of Partial Loss is Essential in Interpreting Merlin Immunohistochemistry When Diagnosing Pleural Mesothelioma.Pathology international
  • EsetismertetésNephrotic Syndrome During Ipilimumab Plus Nivolumab Therapy for Sarcomatoid Malignant Pleural Mesothelioma: A Case Report of Nivolumab Rechallenge Without Recurrence of Nephrotic Syndrome.Cureus
  • EsetismertetésPleural Mesothelioma With Unusual Squamous Differentiation: A Clinicopathological Case Report With Molecular Insights From Whole-Exome Sequencing.Pathology international
  • Correction: Hypomethylation reduced the aggressive potential of human malignant mesothelioma cells.Oncogene
  • FANCD2 knockdown suppresses malignant phenotypes and is associated with caspase/PARP-mediated apoptosis in NCI-H2052 pleural mesothelioma cells.Frontiers in genetics